Harland Medical Systems competitors

Chris Simon is a President and Chief Executive Officer at Haemonetics and Board Member at Haemonetics and is based in Braintree, Massachusetts. He has worked as Senior Partner at McKinsey & Company, Hospital Supply and Scientific Products at Baxter Healthcare Corporation, and Infantry Officer at United States Army. Christopher attended The Wharton School between 1981 and 1985 and Harvard Business School between 1991 and 1993.

Douglas C. Bryant became President and Chief Executive Officer on March 1, 2009. Prior to joining Quidel, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, he held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.